IP Library › Granted Patent US 12,622,781
Granted Patent B2
US 12,622,781 · App. 17/948,669 · Granted May 12, 2026

Tissue based bioprosthetic heart valve

Inventor: Arnaud Humair (Mont-sur-Rolle, CH)
Assignee: Boston Scientific Limited
A61F2/2418A61F2/2415A61F2/2436A61L27/3687A61F2240/001A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,622,781
App. No.
17/948,669
Filed
Sep 20, 2022
Granted
May 12, 2026
Kind
B2
Art Unit
1742
USPC
264/152
Abstract

Embodiments herein relate to bioprosthetic heart valves. In an embodiment, a heart valve replacement system is included having a delivery catheter can include a heart valve accommodation region; and a heart valve disposed around the delivery catheter at the heart valve accommodation region of the delivery catheter, the heart valve can include a frame; and a plurality of valve leaflets coupled to the frame; wherein the valve leaflets include an animal tissue, the animal tissue can include from 15% to 50% by weight water; and from 20% to 70% by weight glycerol; a package defining an interior volume, wherein the delivery catheter and the heart valve are disposed within the package. Other embodiments are also included herein.

Claims (34)

1 . A method of making a heart valve replacement device comprising:

cutting animal tissue into leaflets;

coupling the leaflets to a frame to form a heart valve;

contacting the leaflets with a composition comprising glycerol;

removing moisture from the leaflets in an environment at above room temperature and/or below atmospheric pressure; and

placing the heart valve on a delivery catheter;

wherein coupling the leaflets to the frame occurs prior to removing moisture from the leaflets in the environment at above room temperature and/or below atmospheric pressure;

wherein the leaflets of the heart valve are glutaraldehyde-free when placed on the delivery catheter.

2 . The method of claim 1 , wherein the composition comprises at least 50% glycerol by weight.

3 . The method of claim 2 , wherein the composition comprises no more than 98% glycerol by weight.

4 . The method of claim 3 , wherein the composition comprises at least 70% glycerol by weight.

5 . The method of claim 4 , wherein the composition comprises at least 90% glycerol by weight.

6 . The method of claim 2 , wherein the composition comprises glycerol and water.

7 . The method of claim 6 , wherein the composition further comprises sodium.

8 . The method of claim 2 , further comprising at least partially crimping the heart valve onto the delivery catheter.

9 . The method of claim 8 , further comprising packaging the heart valve and the delivery catheter into a package.

10 . The method of claim 1 , wherein the leaflets have a water content of about 15 to 50 wt. % and a glycerol content of about 20 to about 70 wt. % after removing moisture.

11 . The method of claim 1 , further comprising

coupling an inner skirt to the frame;

contacting the inner skirt with a composition comprising glycerol;

removing moisture from the inner skirt in an environment at above room temperature and/or below atmospheric pressure.

12 . The method of claim 11 , further comprising

coupling an outer skirt to the frame;

contacting the outer skirt with a composition comprising glycerol;

removing moisture from the outer skirt in an environment at above room temperature and/or below atmospheric pressure.

13 . The method of claim 1 , further comprising

disposing a sheath over the heart valve and at least a portion of the delivery catheter.

14 . The method of claim 13 , wherein an outside waist diameter of the sheath is less than 15 mm.

15 . The method of claim 14 , wherein the sheath has an inner diameter of 18 F or smaller.

16 . The method of claim 13 , further comprising packaging the heart valve, sheath, and the delivery catheter into a package.

17 . The method of claim 1 , wherein the delivery catheter comprises a balloon.

18 . The method of claim 17 , wherein the delivery catheter defines an inflation lumen.

19 . The method of claim 17 , wherein the balloon is distal relative to the heart valve.

20 . The method of claim 1 , wherein the heart valve is an aortic heart valve.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2023
From: BOSTON SCIENTIFIC LIMITED
To: BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
Reel/Frame 065580/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2022
From: HUMAIR, ARNAUD
To: BOSTON SCIENTIFIC LIMITED
Reel/Frame 062234/0821 →
Continuity (3)
Continuation 17011366 · Sep 3, 2020
Provisional Application 62899405 · Sep 12, 2019
Related Publication 20230055399A1 · Feb 23, 2023
References Cited (26)
US 8361144B2 · Fish et al. · 2013 [cited by applicant]
US 9333075B2 · Biadillah et al. · 2016 [cited by applicant]
US 9414915B2 · Lombardi et al. · 2016 [cited by applicant]
US 9498317B2 · Gautam et al. · 2016 [cited by applicant]
US 10258464B2 · Delaloye et al. · 2019 [cited by applicant]
US 20070154515A1 · Johnson · 2007 [cited by examiner]
US 20080102439A1 · Tian et al. · 2008 [cited by applicant]
US 20080177381A1 · Navia et al. · 2008 [cited by applicant]
US 20100030340A1 · Wolfinbarger et al. · 2010 [cited by applicant]
US 20110301700A1 · Fish · 2011 [cited by examiner]
US 20120016468A1 · Robin · 2012 [cited by examiner]
US 20130158658A1 · Hayzlett · 2013 [cited by applicant]
US 20130325111A1 · Campbell et al. · 2013 [cited by applicant]
US 20130332511A1 · Hala et al. · 2013 [cited by applicant]
US 20150282930A1 · Lehenberger · 2015 [cited by examiner]
US 20170056149A1 · Rajpara · 2017 [cited by examiner]
US 20190224369A1 · Rzany et al. · 2019 [cited by applicant]
US 20210077253A1 · Humair · 2021 [cited by applicant]
WO 2017040684 · 2017 [cited by applicant]
“Office Action,” for Japanese Patent Application No. 2022-516030 mailed Mar. 22, 2023 (10 pages), with English translation. [cited by applicant]
File History for U.S. Appl. No. 17/011,366 downloaded Oct. 21, 2022 (215 pages). [cited by applicant]
“International Preliminary Report on Patentability,” for PCT Application No. PCT/EP2020/075495 mailed Mar. 24, 2022 (9 pages). [cited by applicant]
“International Search Report and Written Opinion,” for PCT Application No. PCT/EP2020/075495 mailed Nov. 30, 2020 (12 pages). [cited by applicant]
“Response to Communication Pursuant to Rules 161(1) and 162 EPC,” for European Patent Application No. 20775587.7 filed Oct. 20, 2022 (14 pages). [cited by applicant]
“Communication pursuant to Article 94(3),” for European Patent Application No. 20775587.7 mailed May 12, 2025 (6 pages). [cited by applicant]
“First Office Action,” for CN Patent Application No. 202080063548.4, mailed Aug. 2, 2024, 15 pages, with English summary. [cited by applicant]